ARK provides an automated insurance compliance solution that utilizes AI and large language models to evaluate Certificates of Insurance and Insurance Policies in as little as 10 seconds. This technology enables brokers, risk managers, and policyholders to quickly identify problematic exclusions and reduce administrative costs associated with compliance management.

Ema utilizes a Generative Workflow Engine™ and a library of AI agents to automate complex workflows in HR, customer support, and data management, enhancing productivity across various enterprise roles. By integrating with hundreds of applications and employing a proprietary EmaFusion™ model, Ema ensures data accuracy and compliance while reducing operational costs.

EVO is a bioengineering company that develops biomanufacturing processes for producing sustainable biomaterials using renewable feedstocks. Their technology provides a viable alternative to traditional materials, significantly lowering carbon emissions and minimizing resource depletion.

Gemini is a licensed digital asset exchange and custodian that provides secure trading and storage solutions for cryptocurrencies. It enables individuals and institutions to manage their digital assets with regulatory compliance and enhanced security measures.

GO offers a fully online vehicle ordering platform that eliminates the need for traditional car ownership, allowing users to select and apply for a new car in under five minutes with no down payment. By leveraging a proprietary system that combines technology and fleet management, GO reduces monthly costs by 15-25% compared to conventional car ownership, providing a hassle-free experience without hidden fees or lengthy negotiations.

HARM provides an AI-powered platform for individuals experiencing harm to quickly access immediate, trusted support. The system intelligently identifies the nature of the reported harm and routes users directly to appropriate, city-approved advocacy, legal, or housing resources. This streamlined process eliminates confusion while generating de-identified data insights to help municipal leaders optimize community support services.

Provides a shared progress tracking platform for coaches and clients, enabling clients to log actions, track goals, and maintain accountability between sessions. Coaches gain measurable insights into client progress and engagement through customizable logs, reminders, and real-time feedback tools, improving the effectiveness of their practice.

Lydia AI is an artificial intelligence platform that generates personalized and predictive health scores by analyzing data from electronic health records, claims, and other health-related sources. This technology enables health insurers to underwrite policies with increased speed and accuracy, improving risk assessment and customer engagement.

Shukun provides AI‑powered digital doctor agents that automatically analyze multimodal medical imaging and clinical data across major organ systems, delivering quantitative assessments, risk scores, and treatment recommendations. The platform leverages a large multimodal medical model, cloud‑based inference pipelines, and FHIR‑compatible APIs to integrate with hospital information systems, offering rapid, consistent diagnostics for hospitals, imaging centers, and health‑screening organizations.

Spaceship is a Continuous Delivery platform that automates the creation of container images from GitHub repositories without the need for Dockerfiles or YAML configurations. It enables instant deployment of applications on Kubernetes, allowing developers to release code changes to customers automatically on any cloud infrastructure.

Zyheal provides a cloud‑based health management platform that consolidates data from wearables, electronic health records, and manual inputs into a single dashboard. The system applies analytics to deliver personalized lifestyle and treatment recommendations, medication reminders, and progress visualizations, while enabling secure data sharing with clinicians for remote monitoring.

The startup develops TCR gene therapy solutions that provide personalized immunotherapy for cancer patients by engineering T-cell receptors to target specific tumor antigens. This approach enhances treatment efficacy and minimizes side effects compared to traditional therapies.